{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:44:43Z","timestamp":1778899483190,"version":"3.51.4"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1093\/gastro\/gox010","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T03:50:02Z","timestamp":1492660202000},"page":"104-112","source":"Crossref","is-referenced-by-count":50,"title":["Ascites, refractory ascites and hyponatremia in cirrhosis"],"prefix":"10.1093","volume":"5","author":[{"given":"Brett","family":"Fortune","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Cardenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"key\n\t\t\t\t20170508102639_gox010-B1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMra1504367","article-title":"Treatment of patients with cirrhosis","volume":"375","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170508102639_gox010-B2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2008.12.015","article-title":"Burden of digestive diseases in the United States. Part I: Overall and upper gastrointestinal diseases","volume":"136","year":"2009","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ajg.2011.314","article-title":"Hospital readmissions among patients with decompensated cirrhosis","volume":"107","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural history of patients hospitalized for management of cirrhotic ascites","volume":"4","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","year":"2006","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis: natural history and prognostic factors","volume":"7","year":"1987","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","year":"1988","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.20632","article-title":"Bacterial translocation (BT) in cirrhosis","volume":"41","year":"2005","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1478-3231.2011.02579.x","article-title":"Endothelial dysfunction in the regulation of cirrhosis and portal hypertension","volume":"32","year":"2012","journal-title":"Liver Int"},{"key":"key\n\t\t\t\t20170508102639_gox010-B10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM198810273191705","article-title":"Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2)","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170508102639_gox010-B11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","year":"2005","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","year":"2010","journal-title":"Gut"},{"key":"key\n\t\t\t\t20170508102639_gox010-B13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0016-5085(80)90793-3","article-title":"Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis","volume":"78","year":"1980","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0002-9343(99)00217-X","article-title":"Hepatic hydrothorax: pathogenesis, diagnosis, and management","volume":"107","year":"1999","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170508102639_gox010-B15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/0003-4819-117-3-215","article-title":"The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites","volume":"117","year":"1992","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170508102639_gox010-B16","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","year":"2013","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","author":"European Association for the Study of the L","year":"2010","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0261-5614(89)90008-3","article-title":"Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake","volume":"8","year":"1989","journal-title":"Clin Nutr"},{"key":"key\n\t\t\t\t20170508102639_gox010-B19","first-page":"65","article-title":"Malnutrition in liver cirrhosis:the influence of protein and sodium","volume":"5","year":"2013","journal-title":"Middle East J Dig Dis"},{"key":"key\n\t\t\t\t20170508102639_gox010-B20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpgasthep0443","article-title":"Nutritional support in patients with chronic liver disease","volume":"3","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B21","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/0016-5085(86)90249-0","article-title":"Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema","volume":"90","year":"1986","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0168-8278(87)80067-3","article-title":"Repeated paracentesis and i.v. albumin infusion to treat \u2018tense\u2019 ascites in cirrhotic patients: a safe alternative therapy","volume":"5","year":"1987","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B23","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","year":"1988","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","article-title":"Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis","volume":"113","year":"1997","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients","volume":"112","year":"1997","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","article-title":"Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites","volume":"152","year":"2017","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B27","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jpainsymman.2015.07.014","article-title":"Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation","volume":"50","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"key\n\t\t\t\t20170508102639_gox010-B28","first-page":"440","article-title":"Palliative care for patients with end-stage liver disease","volume":"17","year":"2015","journal-title":"Curr Gastroenterol Rep"},{"key":"key\n\t\t\t\t20170508102639_gox010-B29","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial","volume":"63","year":"2016","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B30","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/ajg.2014.212","article-title":"Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis","volume":"109","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B31","doi-asserted-by":"crossref","first-page":"\u00a0496","DOI":"10.1016\/j.cgh.2013.08.025","article-title":"Paracentesis is associated with reduced mortality in patients hospitalized with cirrhosis and ascites","volume":"12","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B32","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1007\/s10620-010-1377-0","article-title":"Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF)","volume":"55","year":"2010","journal-title":"Dig Dis Sci"},{"key":"key\n\t\t\t\t20170508102639_gox010-B33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.27077","article-title":"Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures","volume":"60","year":"2014","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170508102639_gox010-B35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/gut.2006.113050","article-title":"Restricted use of albumin for spontaneous bacterial peritonitis","volume":"56","year":"2007","journal-title":"Gut"},{"key":"key\n\t\t\t\t20170508102639_gox010-B36","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","article-title":"Management of cirrhosis and ascites","volume":"350","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170508102639_gox010-B37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis: International Ascites Club","volume":"23","year":"1996","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1478-3231.2010.02272.x","article-title":"Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis","volume":"30","year":"2010","journal-title":"Liver Int"},{"key":"key\n\t\t\t\t20170508102639_gox010-B39","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0016-5085(83)90198-1","article-title":"Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites: relationship between the diuretic response and the activity of the renin-aldosterone system","volume":"84","year":"1983","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B40","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJM198912143212403","article-title":"Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170508102639_gox010-B41","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","article-title":"The North American Study for the Treatment of Refractory Ascites","volume":"124","year":"2003","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B42","first-page":"CD004889","article-title":"TIPS versus paracentesis for cirrhotic patients with refractory ascites","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20170508102639_gox010-B43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2011.04.027","article-title":"Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B44","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJM199109193251201","article-title":"Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170508102639_gox010-B45","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170508102639_gox010-B46","doi-asserted-by":"crossref","first-page":"\u00a01839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","year":"2002","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B47","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","article-title":"Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites","volume":"40","year":"2004","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1478-3231.2005.01095.x","article-title":"Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis","volume":"25","year":"2005","journal-title":"Liver Int"},{"key":"key\n\t\t\t\t20170508102639_gox010-B49","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data","volume":"133","year":"2007","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B50","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jgh.12725","article-title":"Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion","volume":"30","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B51","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","article-title":"Hyponatremia in cirrhosis: results of a patient population survey","volume":"44","year":"2006","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cld.179","article-title":"Hypervolemic hyponatremia: clinical significance and management","volume":"2","year":"2013","journal-title":"Clinical Liver Disease"},{"key":"key\n\t\t\t\t20170508102639_gox010-B53","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510280337","article-title":"Hyponatremia in cirrhosis: from pathogenesis to treatment","volume":"28","year":"1998","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01095898","article-title":"Prognostic value of spontaneous hyponatremia in cirrhosis with ascites","volume":"21","year":"1976","journal-title":"Am J Dig Dis"},{"key":"key\n\t\t\t\t20170508102639_gox010-B55","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/hep.22418","article-title":"Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B56","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11938-016-0094-y","article-title":"The changing role of sodium management in cirrhosis","volume":"14","year":"2016","journal-title":"Curr Treat Options Gastroenterol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-4615-4871-3_34","article-title":"Molecular pharmacology of human vasopressin receptors","volume":"449","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/gut.31.2.204","article-title":"Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites","volume":"31","year":"1990","journal-title":"Gut"},{"key":"key\n\t\t\t\t20170508102639_gox010-B59","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/MJT.0b013e3181ff7a8b","article-title":"Management of refractory ascites","volume":"19","year":"2012","journal-title":"Am J Ther"},{"key":"key\n\t\t\t\t20170508102639_gox010-B60","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170508102639_gox010-B61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2011.08.020","article-title":"Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B62","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.amjmed.2016.09.011","article-title":"Limited efficacy of tolvaptan in patients with cirrhosis and severe hyponatremia: real-life experience","volume":"130","year":"2017","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170508102639_gox010-B63","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/lt.21836","article-title":"Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease","volume":"15","year":"2009","journal-title":"Liver Transpl"},{"key":"key\n\t\t\t\t20170508102639_gox010-B64","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/gast.2003.50143","article-title":"Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial","volume":"124","year":"2003","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B65","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jhep.2003.50021","article-title":"A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial","volume":"37","year":"2003","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B66","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12876-015-0297-z","article-title":"The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials","volume":"15","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B67","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/apt.12025","article-title":"Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia","volume":"36","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20170508102639_gox010-B68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.20517","article-title":"Serum sodium predicts mortality in patients listed for liver transplantation","volume":"41","year":"2005","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B69","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/lt.20329","article-title":"Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone","volume":"11","year":"2005","journal-title":"Liver Transpl"},{"key":"key\n\t\t\t\t20170508102639_gox010-B70","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1136\/gut.2006.102764","article-title":"MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation","volume":"56","year":"2007","journal-title":"Gut"},{"key":"key\n\t\t\t\t20170508102639_gox010-B71","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1053\/j.gastro.2006.02.017","article-title":"Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation","volume":"130","year":"2006","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B72","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/lt.21154","article-title":"The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study","volume":"13","year":"2007","journal-title":"Liver Transpl"},{"key":"key\n\t\t\t\t20170508102639_gox010-B73","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.22846","article-title":"Impact of pretransplant hyponatremia on outcome following liver transplantation","volume":"49","year":"2009","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B74","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/ajg.2009.293","article-title":"Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis","volume":"104","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B75","doi-asserted-by":"crossref","first-page":"\u00a01199","DOI":"10.1016\/j.jhep.2012.07.020","article-title":"Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jhep.2006.09.012","article-title":"Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites","volume":"46","year":"2007","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B77","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/hep.21901","article-title":"Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome","volume":"46","year":"2007","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508102639_gox010-B78","doi-asserted-by":"crossref","first-page":"\u00a0587","DOI":"10.1016\/j.ejim.2011.06.013","article-title":"The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study","volume":"22","year":"2011","journal-title":"Eur J Intern Med"},{"key":"key\n\t\t\t\t20170508102639_gox010-B79","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2010.02.036","article-title":"Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B80","doi-asserted-by":"crossref","first-page":"\u00a0108","DOI":"10.1136\/gutjnl-2011-300157","article-title":"Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity","volume":"61","year":"2012","journal-title":"Gut"},{"key":"key\n\t\t\t\t20170508102639_gox010-B81","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4254\/wjh.v7.i12.1685","article-title":"Efficacy of tolvaptan in patients with refractory ascites in a clinical setting","volume":"7","year":"2015","journal-title":"World J Hepatol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B82","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/hepr.12455","article-title":"Therapeutic effects of short- and intermediate-term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosis","volume":"45","year":"2015","journal-title":"Hepatol Res"},{"key":"key\n\t\t\t\t20170508102639_gox010-B83","doi-asserted-by":"crossref","first-page":"11400","DOI":"10.3748\/wjg.v20.i32.11400","article-title":"Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20170508102639_gox010-B84","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170508102639_gox010-B85","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1089\/jpm.2013.0167","article-title":"Integration of palliative care in end-stage liver disease and liver transplantation","volume":"17","year":"2014","journal-title":"J Palliat Med"}],"container-title":["Gastroenterology Report"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/gastro\/article-pdf\/5\/2\/104\/16720566\/gox010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T06:24:02Z","timestamp":1569047042000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/gastro\/article-lookup\/doi\/10.1093\/gastro\/gox010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":85,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,4,24]]},"published-print":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1093\/gastro\/gox010","relation":{},"ISSN":["2052-0034"],"issn-type":[{"value":"2052-0034","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]}}}